InvestorsHub Logo
Followers 21
Posts 3570
Boards Moderated 0
Alias Born 12/18/2019

Re: JPG77 post# 196853

Wednesday, 12/15/2021 10:31:36 AM

Wednesday, December 15, 2021 10:31:36 AM

Post# of 233147
Show me one that meet a statistically significant protocol endpoint. You can't find one. The trials are too small, LL's performance was not strong enough. For example, Long CoV -- the NOWHERE did the company say the results met endpoints. Instead they referred to numerically higher difference -- that is directional and certainly not statistically significant. The company is only claiming HIV Phase 3 results are significant. That's all. And they were rejected for BTD.

mTNBC has only 10 patients in their trial. NASH open label is not claimed as statistically significant (again small trial).

The way companies get BTD is having statistically significant "breakthrough" results. mTNBC and NASH did not have them and were not "breakthrough" results even if they were. GvHD failed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News